Claudia FreyMar30Cytosurge launches cell line engineering services based on proprietary FluidFM® technologyby Claudia Frey | March 30, 2022200Zurich | Genetically engineered cell lines have become an invaluable tool in biological research and drug discovery. Nobel-prize winning CRISPR technology has opened up multiple opportunities for gene... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 30, 2022
Claudia FreyJan18R&D project by Cytosurge and the Laboratory of Biosensors and Bioelectronics at the Swiss Federal Institute of Technology receives funding by Innosuisseby Claudia Frey | January 18, 2022231Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation, is delighted to announce that together with the Laboratory of Biosensors and Bioelectronics (LBB) [2] at the ... Read more > Press ReleaseCorporateFluidFM ApplicationsJan 18, 2022
Claudia FreyAug04Partnership between Central Scientific Commerce and Cytosurgeby Claudia Frey | August 4, 2021722Zurich | We are delighted to announce our collaboration with CSC, a well-established and renowned Japanese organization specialized in the distribution of systems for life science research. Within thi... Read more > Press ReleaseCorporateAug 4, 2021
Claudia FreyMar24Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeksby Claudia Frey | March 24, 2021671Zurich | Cytosurge [1] , a leading global provider for precision single cell manipulation [2] , announced today that its pioneering, patented FluidFM nano-probe enabled CRISPR multiplexing to generate... Read more > Press ReleaseCorporateFluidFM ApplicationsMar 24, 2021
Claudia FreyJan27Partnership between RAMCON & Cytosurgeby Claudia Frey | January 27, 2021535Zurich | We are delighted to announce that RAMCON has been appointed as distributor in the Nordic Countries. RAMCON will distribute our FluidFM BIO Series lab solutions that enable cutting-edge experi... Read more > Press ReleaseCorporateJan 27, 2021
Claudia FreyAug26Cytosurge announces appointment of Thomas Bachmann to board of directorsby Claudia Frey | August 26, 20201023Zurich | We are pleased to announce Thomas Bachmann as a new member of our Board of Directors. Thanks to his proven and long-standing strategic management experience and his extensive network in the b... Read more > Press ReleaseCorporateAug 26, 2020
Claudia FreyJul23Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americasby Claudia Frey | July 23, 2020642Waltham, Mass. & Zurich | Olympus [1] , a leading manufacturer of high-end research microscopes, and Cytosurge [2] , a precision manufacturer of cell manipulation technologies, have entered a co-marke... Read more > Press ReleaseCorporateJul 23, 2020
Claudia FreyMay04Harvard's Wyss Institute joins forces with Cytosurge to improve CRISPR-based multiplexed gene editingby Claudia Frey | May 4, 20201043Boston & Zurich | By Benjamin Boettner | Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University [1] and Cytosurge AG [2] , a company manufacturing unique high-precision ... Read more > Press ReleaseCorporateFluidFM ApplicationsMay 4, 2020
Claudia FreyAug21Cytosurge AG announces spin-off of its 3D Printing business unitby Claudia Frey | August 21, 20192831Zurich | The 3D Printing business unit of Cytosurge has been recognized as the technological global market leader for additive manufacturing of microscopically small metal components. We are pleased t... Read more > Press ReleaseCorporateSpin-off ExaddonAug 21, 2019
Claudia FreyJul09Partnership between Olympus Europe & Cytosurgeby Claudia Frey | July 9, 20191121Zurich & Hamburg | Olympus Europe and Cytosurge have partnered in order to accelerate common innovation of next-generation tools for single cell experiments and to expand the distribution of the versa... Read more > Press ReleaseCorporateJul 9, 2019
Claudia FreyJun29Premium Partnership between Bruker & Cytosurgeby Claudia Frey | June 29, 2018551Zurich | Cytosurge AG, a Swiss company that develops, manufactures and distributes scientific high-precision nanotechnology instruments and robotic systems based on its patented FluidFM® technology, a... Read more > Press ReleaseCorporateJun 29, 2018
Claudia FreyDec07Partnership between JPK Instruments & Cytosurgeby Claudia Frey | December 7, 2017496Zurich | Cytosurge, a Swiss company that develops and distributes scientific measuring instruments and robotic systems based on its patented FluidFM® technology, and JPK Instruments, a world-leading m... Read more > Press ReleaseCorporateDec 7, 2017
